We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.72B
AUM Growth
-$344M
Cap. Flow
-$310M
Cap. Flow %
-18%
Top 10 Hldgs %
22.96%
Holding
279
New
14
Increased
72
Reduced
169
Closed
14

Top Buys

Rank Stock Value
1
TTGT icon
TechTarget
TTGT
+$9.17M
2
DOCS icon
Doximity
DOCS
+$7.51M
3
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
+$5.78M
4
CLNE icon
Clean Energy Fuels
CLNE
+$5.35M
5
ZUO
Zuora, Inc.
ZUO
+$4.15M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$26.8M
2
WNS
WNS Holdings
WNS
+$15.7M
3
SIMO icon
Silicon Motion
SIMO
+$14.8M
4
ON icon
ON Semiconductor
ON
+$13.2M
5
WWE
World Wrestling Entertainment
WWE
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 27.05%
2 Healthcare 26.07%
3 Industrials 15.04%
4 Consumer Discretionary 11.17%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWI
226
DELISTED
SolarWinds Corporation Common Stock
SWI
$1.13M 0.07%
145,385
-43,496
-23% -$417K
EBS icon
227
Emergent Biosolutions
EBS
$229M
$1.12M 0.07%
53,396
-208,137
-80% -$5.79M
BRK.B icon
228
Berkshire Hathaway Class B
BRK.B
$1.14T
$1.12M 0.06%
4,184
-250
-6% -$71.1K
SMID icon
229
Smith-Midland
SMID
$146M
$1.09M 0.06%
40,597
-926
-2% -$17.8K
IRD
230
Opus Genetics
IRD
$302M
$1.09M 0.06%
540,348
+212,854
+65% +$459K
TTD icon
231
Trade Desk
TTD
$6.29B
$1.08M 0.06%
18,040
-24,575
-58% -$1.4M
FLWS icon
232
1-800-Flowers.com
FLWS
$255M
$1.03M 0.06%
159,336
-2,678
-2% -$23.7K
PRVB
233
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$997K 0.06%
221,601
-4,184
-2% -$19.1K
PBYI icon
234
Puma Biotechnology
PBYI
$442M
$918K 0.05%
387,539
-118,527
-23% -$346K
ABBV icon
235
AbbVie
ABBV
$438B
$877K 0.05%
6,531
-100
-2% -$14.3K
AAPL icon
236
Apple
AAPL
$4.5T
$843K 0.05%
6,100
– –
TDY icon
237
Teledyne Technologies
TDY
$32B
$823K 0.05%
2,439
-65
-3% -$24.8K
COLM icon
238
Columbia Sportswear
COLM
$2.92B
$788K 0.05%
11,706
-744
-6% -$54.5K
DENN
239
DELISTED
Denny's
DENN
$729K 0.04%
77,468
-1,378
-2% -$13.2K
LLY icon
240
Eli Lilly
LLY
$1.1T
$692K 0.04%
2,140
– –
ABT icon
241
Abbott
ABT
$188B
$657K 0.04%
6,786
-150
-2% -$16K
URGN icon
242
UroGen Pharma
URGN
$2.26B
$619K 0.04%
74,431
-36,026
-33% -$298K
CVX icon
243
Chevron
CVX
$382B
$580K 0.03%
4,037
-214
-5% -$32.6K
NATI
244
DELISTED
National Instruments Corp
NATI
$526K 0.03%
13,936
-380
-3% -$14.4K
WKME
245
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$520K 0.03%
+61,140
New +$632K
HAS icon
246
Hasbro
HAS
$13.3B
$515K 0.03%
7,645
-216
-3% -$17.1K
MRK icon
247
Merck
MRK
$323B
$449K 0.03%
5,208
-318
-6% -$28.4K
MCO icon
248
Moody's
MCO
$82.8B
$447K 0.03%
1,840
-50
-3% -$14.5K
PEP icon
249
PepsiCo
PEP
$188B
$431K 0.03%
2,643
-335
-11% -$57.7K
BRK.A icon
250
Berkshire Hathaway Class A
BRK.A
$1.14T
$406K 0.02%
1
– –
8 9
10
11 12

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Rice Hall James & Associates held 279 positions worth $1.72B, down 17% from $2.07B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Rice Hall James & Associates withdrew a net $310M in Q3 2022, closing 14 positions and reducing 169 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $7.39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in TechTarget worth $8.44M.

  • Rice Hall James & Associates's largest Q3 2022 buy was TechTarget: 142,597 shares worth $8.44M.
  • Rice Hall James & Associates added most to Upland Software in Q3 2022, an estimated $3.67M increase.
  • Rice Hall James & Associates's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $26.8M.
  • Rice Hall James & Associates fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $7.39M.
  • Rice Hall James & Associates's ten largest holdings make up 23% of its $1.72B portfolio in Q3 2022.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q3 2022.
  • Rice Hall James & Associates's portfolio value fell 17% quarter-over-quarter to $1.72B.

Based on Rice Hall James & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.